Leukemia-associated antigens (e.g., CD33 and CD123) are usually strongly expressed in AML cells (especially in NPM1-mutated AML cells [106–108]) but can also be detected in normal hematopoietic stem cells and in extramedullary tissues (e.g., CD123 in endothelial cells). Here, CD33 is linked to acute myeloid leukemia.